Table 1.
Summary of Baseline Clinical Characteristics of Patients With and Without a Clinical Diagnosis of an Anxiety Disorder
| Characteristics |
Anxiety disorder (N=550; 27.9%) |
No anxiety disorder (N=1424; 72.1%) |
P Value |
|---|---|---|---|
| Age, mean (SD), y | 50.6 (12.0) | 51.5 (12.6) | 0.140 |
| Women, n (%) | 361 (65.6) | 946 (66.4) | 0.738 |
| White race, n (%) | 511 (92.9) | 1223 (85.9) | <0.001* |
| BMI, mean (SD), kg/m2 | 29.3 (6.5) | 29.0 (6.4) | 0.347 |
| Hypertension, n (%) | 238 (43.3) | 602 (42.3) | 0.688 |
| Diabetes, n (%) | 76 (13.8) | 139 (9.8) | 0.011* |
| Hyperlipidemia, n (%) | 331 (60.2) | 762 (53.5) | 0.007* |
| eGFR <60 mL/min per 1.73 m2, n (%) | 68 (12.4) | 203 (14.3) | 0.269 |
| History of MI, n (%) | 92 (17.2) | 208 (15.1) | 0.250 |
| History of vascular disease, n (%) | 61 (11.1) | 117 (8.2) | 0.050 |
| Family history of CAD, n (%) | 330 (60.0) | 785 (55.1) | 0.050 |
| Smoking status, n (%) | |||
| Never smoked | 285 (51.8) | 779 (54.7) | |
| Former smoker | 196 (35.6) | 476 (33.4) | |
| Current smoker | 68 (12.4) | 168 (11.8) | 0.632 |
| Total cholesterol, mean (SD), mg/dL | 181.4 (40.0) | 187.7 (44.4) | 0.003* |
| HDL‐C, mean (SD), mg/dL | 52.6 (17.0) | 54.7 (17.8) | 0.018* |
| LDL‐C, mean (SD), mg/dL | 102.5 (34.1) | 106.5 (38.6) | 0.030* |
| Triglycerides, mean (SD), mg/dL | 131.8 (86.3) | 133.9 (89.8) | 0.638 |
| Psychotropic medication, n (%) | 276 (50.2) | 457 (32.1) | <0.001* |
| Systolic blood pressure, mean (SD), mm Hg | 125.9 (17.1) | 125.8 (17.7) | 0.963 |
| Diastolic blood pressure, mean (SD), mm Hg | 75.7 (9.6) | 76.2 (10.1) | 0.291 |
BMI indicates body mass index; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; and MI, myocardial infarction.
*
P value <0.05.